Neuropsychiatric Adverse Events During 12 Months of Treatment With Efavirenz in Treatment-Naïve HIV-Infected Patients in China: A Prospective Cohort Study

Neuropsychiatric Adverse Events During 12 Months of Treatment With Efavirenz in Treatment-Naïve HIV-Infected Patients in China: A Prospective Cohort Study

Background: Efavirenz (EFV) is widely used in antiretroviral therapy (ART), but the incidence and risk factors of neuropsychiatric adverse events (NPAEs) after EFV treatment have rarely been studied in Chinese ART naïve patients.Methods: This prospective cohort study assessed HIV-infected patients i...

Full description

Bibliographic Details
Main Authors: Wei Hua, Sen Wang, Xi Wang, Ying Shao, Yali Wang, Jiangzhu Ye, Bin Su, Taiyi Jiang, Tong Zhang, Hao Wu, An Liu, Qunhui Li, Supriya D. Mahajan, Zaicun Li, Lijun Sun, Lili Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Psychiatry
Subjects:
efavirenz
antiretroviral therapy
anxiety
depression
sleep disturbances
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.579448/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.579448/full

Similar Items